Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$33.6K Buy
507
+281
+124% +$18.2K 0.01% 664
2025
Q3
$15.2K Buy
226
+22
+11% +$1.74K ﹤0.01% 868
2025
Q2
$17K Buy
204
+14
+7% +$1.1K ﹤0.01% 796
2025
Q1
$12.8K Sell
190
-90
-32% -$7.34K ﹤0.01% 754
2024
Q4
$21.8K Sell
280
-258
-48% -$19.1K ﹤0.01% 730
2024
Q3
$36.1K Buy
538
+15
+3% +$1.23K 0.01% 578
2024
Q2
$58.7K Buy
523
+498
+1,992% +$63K 0.01% 751
2024
Q1
$3.45K Buy
25
+9
+56% +$1.13K 0.01% 370
2023
Q4
$1.99K Hold
16
﹤0.01% 956
2023
Q3
$1.49K Hold
16
﹤0.01% 1112
2023
Q2
$2.03K Buy
+16
New +$1.94K ﹤0.01% 1199

Other funds holding DXCM

ORG Partners's DXCM Position: Q4 2025 in Review

ORG Partners increased its DexCom (DXCM) stake by 124% in Q4 2025, buying an estimated $18.2K and bringing the position to 507 shares worth $33.6K. The position accounts for 0.01% of the portfolio, ranked #664.

ORG Partners first reported a position in DXCM in Q2 2023 and has held it in 11 quarters since. The position peaked at $58.7K in Q2 2024. 920 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

  • ORG Partners held 507 shares of DexCom worth $33.6K as of Q4 2025.
  • ORG Partners bought 281 DexCom shares in Q4 2025, an estimated $18.2K.
  • DexCom made up 0.01% of ORG Partners's portfolio in Q4 2025, its #664 holding.
  • ORG Partners first reported a position in DexCom in Q2 2023 and has held it in 11 quarters since.
  • ORG Partners's DexCom position peaked at $58.7K in Q2 2024.
  • 920 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on ORG Partners's 13F filing for Q4 2025, filed 14 Jan 2026.